Literature DB >> 18030574

Signet-ring cell carcinoma of the esophagus associated with Barrett's epithelium: report of a case.

Kiichi Maezato1, Tadashi Nishimaki, Mariko Oshiro, Toshimitu Yamashiro, Hideaki Sasaki, Yasunori Sashida.   

Abstract

We herein report a case of infiltrative esophageal signet-ring cell carcinoma resembling gastric signet-ring cell carcinoma. Grossly, the tumor was a diffusely infiltrative carcinoma involving the lower esophagus measuring 11 cm in diameter. The tumor extensively metastasized to the cervical, mediastinal, and abdominal lymph nodes, and the patient died of peritonitis and pleuritis carcinomatosa soon after undergoing a radical esophagectomy. Histologically, the tumor was signet-ring cell carcinoma covered with normal squamous epithelium. However, the most superficial part of the tumor center contained a region of Barrett's mucosa with incomplete-type intestinal metaplasia and a well-differentiated adenocarcinoma component with goblet cells. The expression of cytokeratins 7 and 20 also indicated that both the Barrett's mucosa and the signet-ring cell carcinoma had an esophageal origin. Esophageal signet-ring cell carcinoma with diffuse infiltrative growth is quite rare, and may need a special treatment strategy because of its highly aggressive behavior and poor treatment outcome.

Entities:  

Mesh:

Year:  2007        PMID: 18030574     DOI: 10.1007/s00595-007-3533-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

Authors:  A H Ormsby; J R Goldblum; T W Rice; J E Richter; G W Falk; M F Vaezi; T L Gramlich
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

Review 2.  [A case of adenosquamous carcinoma of the esophagus, having signet ring cell carcinoma and mucinous adenocarcinoma in the component of well differentiated adenocarcinoma].

Authors:  H Tomimatsu; A Yanagisawa; K Kubo; Y Kato; Y Baba; S Kaku
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1996-09

3.  "Barrett's esophagus" adenocarcinoma: a case report.

Authors:  T Nakamura; H Tohyama; Y Nagamachi
Journal:  Jpn J Surg       Date:  1980-06

4.  Esophageal mucoepidermoid carcinoma containing signet-ring cells: three case reports and a literature review.

Authors:  A Matsuki; T Nishimaki; T Suzuki; T Kanda; K Hatakeyama
Journal:  J Surg Oncol       Date:  1999-05       Impact factor: 3.454

5.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry.

Authors:  Keiichi Maruyama; Michio Kaminishi; Ken-Ichi Hayashi; Yoh Isobe; Ichiro Honda; Hitoshi Katai; Kuniyoshi Arai; Yasuhiro Kodera; Atsushi Nashimoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Adenocarcinoma complicating Barrett's esophagus: an analysis of cell proliferation.

Authors:  Y Matsumoto; N Arai; H Mieno; K Murakami; K Ishii; H Mitomi
Journal:  J Gastroenterol       Date:  2001-06       Impact factor: 7.527

8.  Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.

Authors:  Masahiko Yano; Hitoshi Shiozaki; Masatoshi Inoue; Shigeyuki Tamura; Yuichiro Doki; Takushi Yasuda; Yoshiyuki Fujiwara; Toshimasa Tsujinaka; Morito Monden
Journal:  World J Surg       Date:  2002-06-24       Impact factor: 3.352

9.  Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.

Authors:  Katja Ott; Andreas Sendler; Karen Becker; Hans-Joachim Dittler; Hermann Helmberger; Raimonde Busch; Christian Kollmannsberger; J Rüdiger Siewert; Ulrich Fink
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

10.  Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer.

Authors:  U Ribeiro; J J Gama-Rodrigues; A V Safatle-Ribeiro; B Bitelman; R E Ibrahim; M B Ferreira; A A Laudanna; H W Pinotti
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

View more
  7 in total

1.  Metakaryotic stem cell lineages in organogenesis of humans and other metazoans.

Authors:  Elena V Gostjeva; Vera Koledova; Aoy Tomita-Mitchell; Michael Mitchell; Mary A Goetsch; Susannah Varmuza; Janna N Fomina; Firouz Darroudi; William G Thilly
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

Review 2.  Pathology of esophageal cancer and Barrett's esophagus.

Authors:  Shilpa Jain; Sadhna Dhingra
Journal:  Ann Cardiothorac Surg       Date:  2017-03

3.  Barrett's esophageal carcinoma consisting of undifferentiated carcinoma and differentiated adenocarcinoma: report of case.

Authors:  Otohiro Katsube; Shin Saito; Yoshinori Hosoya; Toshihide Komatsubara; Takashi Ui; Kentaro Kurashina; Hidenori Haruta; Toru Zuiki; Takehiko Yamaguchi; Naohiro Sata; Yoshikazu Yasuda
Journal:  Clin J Gastroenterol       Date:  2013-03-31

4.  Signet-ring cell carcinoma of the esophagus in dermatomyositis: a case report with immunohistochemical study.

Authors:  Tadashi Terada
Journal:  J Gastrointest Cancer       Date:  2013-12

5.  A clinicopathologic study of esophageal 860 benign and malignant lesions in 910 cases of consecutive esophageal biopsies.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

6.  Esophageal Cancers: A Clinicopathologic and Immunohistochemical Study of 223 Cases.

Authors:  Tadashi Terada
Journal:  Gastroenterology Res       Date:  2009-05-20

7.  The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China.

Authors:  Lei Chen; Xi Liu; Linggen Gao; Rong Wang; Dewei Gao; Dongyu Bai
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.